BOLT stock

Bolt Biotherapeutics (BOLT) financials · rev $7.7M

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Bolt Biotherapeutics (BOLT) rev $7.7M.

Cached annual income statement
LineFY2025FY2024
Revenue$7.70M$7.69M
Operating Income-$36.1M-$73.0M
Net Income-$33.4M-$63.1M
EPS (Diluted)-$17.85-$1.65
Cached annual balance sheet
LineFY2025FY2024
Total Assets$56.7M$99.6M
Current Assets$30.3M$50.8M
Cash & Equivalents$11.7M$7.21M
PP&E$1.25M$3.14M
Total Liabilities$30.2M$42.4M
Current Liabilities$8.44M$15.9M
Shareholders' Equity$26.5M$57.2M
Retained Earnings-$460.8M-$427.4M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$39.9M-$61.3M
CapEx$72.0K$41.0K
Investing Cash Flow$44.3M$57.6M
Financing Cash Flow$19.0K$108.0K
Net Change in Cash$4.47M-$3.60M
Free Cash Flow-$39.9M-$61.3M
These statements as JSON? API free 100/day

FAQ

What is BOLT P/E and revenue?

Bolt Biotherapeutics (BOLT) rev $7.7M.

What is BOLT revenue?

Bolt Biotherapeutics last cached revenue is $7.70M (FY2025).

Is BOLT profitable?

Bolt Biotherapeutics last cached net income is -$33.4M (FY2025).

What are BOLT total assets?

Bolt Biotherapeutics last cached total assets are $56.7M (FY2025).

What is BOLT free cash flow?

Bolt Biotherapeutics last cached free cash flow is -$39.9M (FY2025).

Not investment advice. Cached statements, not a live tape.